固体瘤中的细胞因子释放综合征
David Synnott1,2,3, David O'Reilly1,3,4, Declan De Freitas1,2,4
1Beaumont Hospital, Dublin, Ireland.
Cancer
|August 23, 2025
概括
细胞因子释放综合征 (CRS) 是一种严重的免疫治疗副作用. 本综述详细介绍了固体瘤的CRS,重点关注独特的挑战和管理策略,以改善患者的治疗结果.
科学领域:
- 癌症学
- 免疫学
- 药理学
背景情况:
- 细胞因子释放综合征 (CRS) 是癌症免疫疗法的常见并发症,如CAR T细胞疗法和双特异性T细胞诱导剂.
- 目前对CRS的管理指南主要针对血液恶性瘤,需要对固体瘤进行特殊考虑.
研究的目的:
- 在固体器官瘤的背景下审查CRS的病理生理学,临床表现和治疗.
- 突显固体瘤中CRS的独特挑战和复杂性,包括瘤微环境和潜在的毒性.
主要方法:
- 对固体瘤中CRS现有研究的文献综述.
- 对病理生理学,临床表现和当前治疗策略的分析.
- 讨论新出现的治疗方法和未来的研究方向.
主要成果:
- 固体瘤由于免疫抑制的微环境和潜在的瘤外影响而存在独特的CRS挑战.
- 早期检测和分类对于有效的CRS管理至关重要.
- 治疗范围从轻度病例的支持性护理到针对性治疗 (例如,托西利祖马布,皮质类固醇) 和重症病例的急诊室支持.
结论:
- 需要个性化治疗方法,以提高固体瘤患者的免疫治疗安全性和疗效.
- 进一步研究风险分层,新疗法和长期结果至关重要.
- 了解固体瘤中的CRS将改善患者护理和治疗策略.
更多相关视频
相关概念视频
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


